HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer

PATHOME: an algorithm for accurately detecting differentially expressed subpathways

(2014) S Nam et al.   ONCOGENE

Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010

(2013) Kyu-Won Jung et al.   Cancer Research and Treatment

An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression

(2013) Jungsun Kim et al.   Cell Reports

HNF4α: a new biomarker in colon cancer?

(2012) Karthikeyani Chellappa et al.   Biomarkers in Medicine

Identifying molecular drivers of gastric cancer through next-generation sequencing

(2012) Han Liang et al.   CANCER LETTERS

AMPK  Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer

(2012) Y. H. Kim et al.   CANCER RESEARCH

The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo

(2012) K. Kato et al.   MOLECULAR CANCER THERAPEUTICS

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma

(2012) Hisashi Iizasa et al.   Viruses-Basel

Diabetes, cancer, and metformin: connections of metabolism and cell proliferation

(2011) Emily Jane Gallagher et al.   Annals of the New York Academy of Sciences

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer

(2011) J. Y. Cho et al.   CLINICAL CANCER RESEARCH

Wnt Signaling Regulates Hepatic Metabolism

(2011) H. Liu et al.   Science Signaling

Trend in gastric cancer: 35 years of surgical experience in Japan

(2011) Keishi Yamashita   WORLD JOURNAL OF GASTROENTEROLOGY

cAMP-mediated regulation of HNF-4α depends on the level of coactivator PGC-1α

(2010) Simon Nitter Dankel et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase

(2010) Yon Hui Kim et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Esophagogastric cancer: Targeted agents

(2010) Geoffrey Y. Ku et al.   CANCER TREATMENT REVIEWS

Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo

(2010) Z. A. Wainberg et al.   CLINICAL CANCER RESEARCH

HNF4α—role in drug metabolism and potential drug target?

(2010) Wendy W Hwang-Verslues et al.   CURRENT OPINION IN PHARMACOLOGY

Trastuzumab in gastric cancer

(2010) Alicia F.C. Okines et al.   EUROPEAN JOURNAL OF CANCER

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer

(2010) Juan Cui et al.   NUCLEIC ACIDS RESEARCH

Gastric cancer,helicobacter pyloriinfection and other risk factors

(2010) Lorenzo Fuccio   World Journal of Gastrointestinal Oncology

Gastric cancer in the era of molecularly targeted agents: current drug development strategies

(2009) Hendrik-Tobias Arkenau   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Hepatocyte Nuclear Factor 4 , a Key Factor for Homeostasis, Cell Architecture, and Barrier Function of the Adult Intestinal Epithelium

(2009) A.-L. Cattin et al.   MOLECULAR AND CELLULAR BIOLOGY

An E2F1-Dependent Gene Expression Program that Determines the Balance between Proliferation and Cell Death

(2008) Timothy C. Hallstrom et al.   CANCER CELL

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols